Disease-Free SurvivalSurvival RatePrognosisNeoplasm StagingTreatment OutcomeSurvival AnalysisRetrospective StudiesNeoplasm Recurrence, LocalCombined Modality TherapyBreast NeoplasmsKaplan-Meier EstimateFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsRecurrenceTumor Markers, BiologicalChemotherapy, AdjuvantLymphatic MetastasisRadiotherapy, AdjuvantProportional Hazards ModelsImmunohistochemistryCell SurvivalRadiotherapy DosageTime FactorsFluorouracilCyclophosphamideCarcinoma, Squamous CellNeoplasm InvasivenessColorectal NeoplasmsCarcinoma, Ductal, BreastMultivariate AnalysisCarcinomaLiver NeoplasmsProspective StudiesAdenocarcinomaReceptors, EstrogenImmunoenzyme TechniquesReceptor, erbB-2Predictive Value of TestsRisk FactorsGene Expression Regulation, NeoplasticSurvivalRemission InductionNeoplasm MetastasisAntineoplastic AgentsCisplatinVincristineLung NeoplasmsGraft SurvivalSalvage TherapyNeoplasm GradingDoxorubicinDisease ProgressionEtoposideDrug Administration ScheduleMethotrexateBone NeoplasmsNeoadjuvant TherapyCohort StudiesPrednisoneNeoplasm, ResidualTransplantation, HomologousHematopoietic Stem Cell TransplantationHodgkin DiseaseLymphoma, Non-HodgkinChemoradiotherapyActuarial AnalysisOvarian NeoplasmsCarcinoma, Non-Small-Cell LungTransplantation, AutologousReceptors, ProgesteronePrecursor Cell Lymphoblastic Leukemia-LymphomaRadiotherapyAge FactorsHead and Neck NeoplasmsSarcomaLymph Node ExcisionCarboplatinNeoplasms, Germ Cell and EmbryonalFree RadicalsBrachytherapyLymph NodesBone Marrow TransplantationNeoplasm ProteinsCarcinoma, HepatocellularBrain NeoplasmsOsteosarcomaRisk AssessmentTamoxifenAntineoplastic Agents, HormonalPancreatic NeoplasmsTesticular NeoplasmsAntibodies, MonoclonalPaclitaxelStomach NeoplasmsRectal NeoplasmsMediastinal NeoplasmsReverse Transcriptase Polymerase Chain ReactionCell Line, TumorCytarabineDose Fractionation